{"entity":{"type":"insider","cik":"0001724311","url":"/insider/0001724311","json_url":"/insider/0001724311.json","name":"Schuth Alexander O.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":121,"n_filings":54,"first":"2018-12-12","last":"2026-08-13","span_basis":"filed_date"},"name_variants":[{"name":"Schuth Alexander O.","source":"filing","n_filings":54,"first_seen":"2018-12-12","last_seen":"2026-08-13"}],"transactions":[{"id":9295385,"accession":"0001724311-26-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001724311-26-000013","line_url":"/filing/0001724311-26-000013#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2857.0,"shares_display":"2,857","price_per_share":25.07,"price_display":"25.07","price_state":"stated","total_value":71624.99,"total_display":"71,624.99","total_whole":"71,625","shares_owned_after":281763.0,"shares_owned_after_display":"281,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-11","filed_date":"2026-08-13","scope":"insider"},{"id":5758247,"accession":"0001724311-26-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001724311-26-000005","line_url":"/filing/0001724311-26-000005#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17218.0,"shares_display":"17,218","price_per_share":16.5,"price_display":"16.50","price_state":"stated","total_value":284097.0,"total_display":"284,097.00","total_whole":"284,097","shares_owned_after":282828.0,"shares_owned_after_display":"282,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-08","scope":"insider"},{"id":4481004,"accession":"0001724311-25-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001724311-25-000011","line_url":"/filing/0001724311-25-000011#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2937.0,"shares_display":"2,937","price_per_share":13.58,"price_display":"13.58","price_state":"stated","total_value":39884.46,"total_display":"39,884.46","total_whole":"39,884","shares_owned_after":242346.0,"shares_owned_after_display":"242,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-14","scope":"insider"},{"id":4679589,"accession":"0001714899-25-000050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-25-000050","line_url":"/filing/0001714899-25-000050#line-2","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2907.0,"shares_display":"2,907","price_per_share":20.81,"price_display":"20.81","price_state":"stated","total_value":60494.67,"total_display":"60,494.67","total_whole":"60,495","shares_owned_after":244308.0,"shares_owned_after_display":"244,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-07","filed_date":"2025-01-08","scope":"insider"},{"id":4679584,"accession":"0001714899-25-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-25-000050","line_url":"/filing/0001714899-25-000050#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12255.0,"shares_display":"12,255","price_per_share":20.22,"price_display":"20.22","price_state":"stated","total_value":247796.1,"total_display":"247,796.10","total_whole":"247,796","shares_owned_after":247215.0,"shares_owned_after_display":"247,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-08","scope":"insider"},{"id":2747178,"accession":"0001714899-24-000218","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001714899-24-000218","line_url":"/filing/0001714899-24-000218","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15558.0,"shares_display":"15,558","price_per_share":29.906571538758197,"price_display":"29.91","price_state":"stated","total_value":465286.44,"total_display":"465,286.44","total_whole":"465,286","shares_owned_after":181291.0,"shares_owned_after_display":"181,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-07","filed_date":"2024-11-12","scope":"insider","n_lines":3},{"id":2227431,"accession":"0001714899-24-000195","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001714899-24-000195","line_url":"/filing/0001714899-24-000195#line-3","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2547.0,"shares_display":"2,547","price_per_share":24.78,"price_display":"24.78","price_state":"stated","total_value":63114.66,"total_display":"63,114.66","total_whole":"63,115","shares_owned_after":178066.0,"shares_owned_after_display":"178,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-21","filed_date":"2024-08-22","scope":"insider"},{"id":2227426,"accession":"0001714899-24-000195","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-24-000195","line_url":"/filing/0001714899-24-000195","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5806.0,"shares_display":"5,806","price_per_share":23.64562349293834,"price_display":"23.65","price_state":"stated","total_value":137286.49,"total_display":"137,286.49","total_whole":"137,286","shares_owned_after":180613.0,"shares_owned_after_display":"180,613","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-20","filed_date":"2024-08-22","scope":"insider","n_lines":2},{"id":2406718,"accession":"0001714899-24-000177","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-24-000177","line_url":"/filing/0001714899-24-000177#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2272.0,"shares_display":"2,272","price_per_share":22.89,"price_display":"22.89","price_state":"stated","total_value":52006.08,"total_display":"52,006.08","total_whole":"52,006","shares_owned_after":186419.0,"shares_owned_after_display":"186,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-13","filed_date":"2024-08-15","scope":"insider"},{"id":2366520,"accession":"0001714899-24-000059","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-24-000059","line_url":"/filing/0001714899-24-000059#line-2","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20128.0,"shares_display":"20,128","price_per_share":17.66,"price_display":"17.66","price_state":"stated","total_value":355460.48,"total_display":"355,460.48","total_whole":"355,460","shares_owned_after":187341.0,"shares_owned_after_display":"187,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-14","filed_date":"2024-02-15","scope":"insider"},{"id":2366517,"accession":"0001714899-24-000059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-24-000059","line_url":"/filing/0001714899-24-000059#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2716.0,"shares_display":"2,716","price_per_share":17.29,"price_display":"17.29","price_state":"stated","total_value":46959.64,"total_display":"46,959.64","total_whole":"46,960","shares_owned_after":207469.0,"shares_owned_after_display":"207,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-13","filed_date":"2024-02-15","scope":"insider"},{"id":2615812,"accession":"0001714899-24-000036","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-24-000036","line_url":"/filing/0001714899-24-000036#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9972.0,"shares_display":"9,972","price_per_share":19.43,"price_display":"19.43","price_state":"stated","total_value":193755.96,"total_display":"193,755.96","total_whole":"193,756","shares_owned_after":539307.0,"shares_owned_after_display":"539,307","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-01-09","scope":"insider"},{"id":7823174,"accession":"0001714899-23-000137","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000137","line_url":"/filing/0001714899-23-000137#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2522.0,"shares_display":"2,522","price_per_share":23.17,"price_display":"23.17","price_state":"stated","total_value":58434.74,"total_display":"58,434.74","total_whole":"58,435","shares_owned_after":518989.0,"shares_owned_after_display":"518,989","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-23","filed_date":"2023-08-25","scope":"insider"},{"id":8306997,"accession":"0001714899-23-000134","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000134","line_url":"/filing/0001714899-23-000134#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2478.0,"shares_display":"2,478","price_per_share":22.59,"price_display":"22.59","price_state":"stated","total_value":55978.02,"total_display":"55,978.02","total_whole":"55,978","shares_owned_after":521511.0,"shares_owned_after_display":"521,511","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-21","filed_date":"2023-08-23","scope":"insider"},{"id":8181781,"accession":"0001714899-23-000124","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000124","line_url":"/filing/0001714899-23-000124#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2772.0,"shares_display":"2,772","price_per_share":23.67,"price_display":"23.67","price_state":"stated","total_value":65613.24,"total_display":"65,613.24","total_whole":"65,613","shares_owned_after":518989.0,"shares_owned_after_display":"518,989","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-14","filed_date":"2023-08-16","scope":"insider"},{"id":8691383,"accession":"0001714899-23-000121","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000121","line_url":"/filing/0001714899-23-000121#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2853.0,"shares_display":"2,853","price_per_share":24.18,"price_display":"24.18","price_state":"stated","total_value":68985.54,"total_display":"68,985.54","total_whole":"68,986","shares_owned_after":521761.0,"shares_owned_after_display":"521,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-10","filed_date":"2023-08-14","scope":"insider"},{"id":8757222,"accession":"0001714899-23-000109","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001714899-23-000109","line_url":"/filing/0001714899-23-000109#line-3","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9702.0,"shares_display":"9,702","price_per_share":30.01,"price_display":"30.01","price_state":"stated","total_value":291157.02,"total_display":"291,157.02","total_whole":"291,157","shares_owned_after":518989.0,"shares_owned_after_display":"518,989","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-18","filed_date":"2023-07-19","scope":"insider"},{"id":8757220,"accession":"0001714899-23-000109","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-23-000109","line_url":"/filing/0001714899-23-000109#line-2","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":29.6,"price_display":"29.60","price_state":"stated","total_value":296000.0,"total_display":"296,000.00","total_whole":"296,000","shares_owned_after":528691.0,"shares_owned_after_display":"528,691","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-17","filed_date":"2023-07-19","scope":"insider"},{"id":8130913,"accession":"0001714899-23-000076","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001714899-23-000076","line_url":"/filing/0001714899-23-000076","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":28.6044,"price_display":"28.60","price_state":"stated","total_value":286044.0,"total_display":"286,044.00","total_whole":"286,044","shares_owned_after":529491.0,"shares_owned_after_display":"529,491","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-15","filed_date":"2023-05-17","scope":"insider","n_lines":2},{"id":8453441,"accession":"0001714899-23-000055","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001714899-23-000055","line_url":"/filing/0001714899-23-000055#line-4","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4898.0,"shares_display":"4,898","price_per_share":25.04,"price_display":"25.04","price_state":"stated","total_value":122645.92,"total_display":"122,645.92","total_whole":"122,646","shares_owned_after":528691.0,"shares_owned_after_display":"528,691","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-13","filed_date":"2023-04-14","scope":"insider"},{"id":8453435,"accession":"0001714899-23-000055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-23-000055","line_url":"/filing/0001714899-23-000055#line-2","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5102.0,"shares_display":"5,102","price_per_share":25.04,"price_display":"25.04","price_state":"stated","total_value":127754.08,"total_display":"127,754.08","total_whole":"127,754","shares_owned_after":528691.0,"shares_owned_after_display":"528,691","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-12","filed_date":"2023-04-14","scope":"insider"},{"id":8594483,"accession":"0001714899-23-000030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-23-000030","line_url":"/filing/0001714899-23-000030#line-2","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3497.0,"shares_display":"3,497","price_per_share":30.09,"price_display":"30.09","price_state":"stated","total_value":105224.73,"total_display":"105,224.73","total_whole":"105,225","shares_owned_after":528691.0,"shares_owned_after_display":"528,691","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-15","scope":"insider"},{"id":8662556,"accession":"0001714899-23-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000020","line_url":"/filing/0001714899-23-000020#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1521.0,"shares_display":"1,521","price_per_share":30.89,"price_display":"30.89","price_state":"stated","total_value":46983.69,"total_display":"46,983.69","total_whole":"46,984","shares_owned_after":499902.0,"shares_owned_after_display":"499,902","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-08","filed_date":"2023-02-10","scope":"insider"},{"id":8594476,"accession":"0001714899-23-000018","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001714899-23-000018","line_url":"/filing/0001714899-23-000018","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":29.533876,"price_display":"29.53","price_state":"stated","total_value":295338.76,"total_display":"295,338.76","total_whole":"295,339","shares_owned_after":497287.0,"shares_owned_after_display":"497,287","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-19","scope":"insider","n_lines":2},{"id":7823166,"accession":"0001714899-23-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000014","line_url":"/filing/0001714899-23-000014#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2636.0,"shares_display":"2,636","price_per_share":28.44,"price_display":"28.44","price_state":"stated","total_value":74967.84,"total_display":"74,967.84","total_whole":"74,968","shares_owned_after":497173.0,"shares_owned_after_display":"497,173","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-09","scope":"insider"},{"id":9271878,"accession":"0001209191-23-002545","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-002545","line_url":"/filing/0001209191-23-002545#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2912.0,"shares_display":"2,912","price_per_share":28.7,"price_display":"28.70","price_state":"stated","total_value":83574.4,"total_display":"83,574.40","total_whole":"83,574","shares_owned_after":492309.0,"shares_owned_after_display":"492,309","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-09","scope":"insider"},{"id":8605219,"accession":"0001209191-23-002181","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-002181","line_url":"/filing/0001209191-23-002181#line-2","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2912.0,"shares_display":"2,912","price_per_share":28.7,"price_display":"28.70","price_state":"stated","total_value":83574.4,"total_display":"83,574.40","total_whole":"83,574","shares_owned_after":149828.0,"shares_owned_after_display":"149,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-05","scope":"insider"},{"id":6941035,"accession":"0001714899-22-000127","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-22-000127","line_url":"/filing/0001714899-22-000127#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2576.0,"shares_display":"2,576","price_per_share":33.22,"price_display":"33.22","price_state":"stated","total_value":85574.72,"total_display":"85,574.72","total_whole":"85,575","shares_owned_after":467471.0,"shares_owned_after_display":"467,471","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-19","filed_date":"2022-08-23","scope":"insider"},{"id":6311992,"accession":"0001714899-22-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-22-000040","line_url":"/filing/0001714899-22-000040#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2803.0,"shares_display":"2,803","price_per_share":34.68,"price_display":"34.68","price_state":"stated","total_value":97208.04,"total_display":"97,208.04","total_whole":"97,208","shares_owned_after":465047.0,"shares_owned_after_display":"465,047","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-11","filed_date":"2022-02-15","scope":"insider"},{"id":6191660,"accession":"0001714899-22-000034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-22-000034","line_url":"/filing/0001714899-22-000034#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1423.0,"shares_display":"1,423","price_per_share":37.1045,"price_display":"37.10","price_state":"stated","total_value":52799.7035,"total_display":"52,799.70","total_whole":"52,800","shares_owned_after":460564.0,"shares_owned_after_display":"460,564","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-09","filed_date":"2022-02-11","scope":"insider"},{"id":6402643,"accession":"0001714899-22-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-22-000005","line_url":"/filing/0001714899-22-000005#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2846.0,"shares_display":"2,846","price_per_share":44.77,"price_display":"44.77","price_state":"stated","total_value":127415.42,"total_display":"127,415.42","total_whole":"127,415","shares_owned_after":457737.0,"shares_owned_after_display":"457,737","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-07","scope":"insider"},{"id":4195875,"accession":"0001714899-21-000116","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-21-000116","line_url":"/filing/0001714899-21-000116","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":42.2736,"price_display":"42.27","price_state":"stated","total_value":422736.0,"total_display":"422,736.00","total_whole":"422,736","shares_owned_after":453083.0,"shares_owned_after_display":"453,083","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-06","filed_date":"2021-12-08","scope":"insider","n_lines":2},{"id":4399515,"accession":"0001714899-21-000107","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-21-000107","line_url":"/filing/0001714899-21-000107","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":52.840414,"price_display":"52.84","price_state":"stated","total_value":528404.14,"total_display":"528,404.14","total_whole":"528,404","shares_owned_after":466366.0,"shares_owned_after_display":"466,366","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-04","filed_date":"2021-11-08","scope":"insider","n_lines":2},{"id":4580273,"accession":"0001714899-21-000094","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-21-000094","line_url":"/filing/0001714899-21-000094","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":50.56048,"price_display":"50.56","price_state":"stated","total_value":505604.8,"total_display":"505,604.80","total_whole":"505,605","shares_owned_after":477089.0,"shares_owned_after_display":"477,089","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-04","filed_date":"2021-10-06","scope":"insider","n_lines":2},{"id":5169264,"accession":"0001714899-21-000090","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001714899-21-000090","line_url":"/filing/0001714899-21-000090","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":55.548485,"price_display":"55.55","price_state":"stated","total_value":555484.85,"total_display":"555,484.85","total_whole":"555,485","shares_owned_after":476479.0,"shares_owned_after_display":"476,479","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-07","filed_date":"2021-09-09","scope":"insider","n_lines":3},{"id":4801666,"accession":"0001714899-21-000086","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-21-000086","line_url":"/filing/0001714899-21-000086","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2544.0,"shares_display":"2,544","price_per_share":49.601603773584905,"price_display":"49.60","price_state":"stated","total_value":126186.48,"total_display":"126,186.48","total_whole":"126,186","shares_owned_after":484234.0,"shares_owned_after_display":"484,234","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-19","filed_date":"2021-08-23","scope":"insider","n_lines":2},{"id":4740790,"accession":"0001714899-21-000082","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001714899-21-000082","line_url":"/filing/0001714899-21-000082","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724311","owner_name":"Schuth Alexander O.","owner_display_name":"Schuth Alexander O.","owner_url":"/insider/0001724311","role":"Officer (COO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":52.2233028,"price_display":"52.22","price_state":"stated","total_value":522233.028,"total_display":"522,233.03","total_whole":"522,233","shares_owned_after":481782.0,"shares_owned_after_display":"481,782","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-04","filed_date":"2021-08-06","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":"2021-08-04|4740784","ledger_fault":false,"count":{"value":121,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":121,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":121},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001714899","name":"Denali Therapeutics Inc.","url":"/issuer/0001714899","role":"Officer (COFO and Secretary)","n_filings":54,"first_seen":"2018-12-12","last_seen":"2026-08-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001724311","retrieved_at":"2026-08-25T08:03:49+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}